Flow Traders U.S.’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Flow Traders U.S.’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,886	Closed	-$839K	–	1146
2024 Q3	$839K	Buy	+11,886	New	+$828K	0.04%	424
2024 Q2	–	Sell	-3,085	Closed	-$209K	–	989
2024 Q1	$209K	Buy	+3,085	New	+$204K	0.01%	646
2022 Q1	–	Sell	-12,120	Closed	-$807K	–	887
2021 Q4	$807K	Sell	12,120 -2,658	-18%	-$169K	0.04%	342
2021 Q3	$902K	Buy	+14,778	New	+$939K	0.04%	531
2021 Q2	–	Sell	-5,808	Closed	-$353K	–	1028
2021 Q1	$344K	Buy	5,808 +2,325	+67%	+$140K	0.02%	617
2020 Q4	$208K	Sell	3,483 -3,684	-51%	-$210K	0.01%	568
2020 Q3	$391K	Buy	+7,167	New	+$387K	0.03%	379

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Flow Traders U.S.'s IHE Position: Q4 2024 in Review

Flow Traders U.S. sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2024, closing a stake of 11,886 shares — an estimated $839K sold.

Flow Traders U.S. first reported a position in IHE in Q3 2020 and held it in 7 quarters. The position peaked at $902K in Q3 2021. 155 funds tracked by Wall St. Rank hold IHE as of Q4 2024.

Flow Traders U.S. reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2024 after selling out during the quarter.
Flow Traders U.S. sold 11,886 iShares US Pharmaceuticals ETF shares in Q4 2024, an estimated $839K.
Flow Traders U.S. first reported a position in iShares US Pharmaceuticals ETF in Q3 2020 and held it in 7 quarters.
Flow Traders U.S.'s iShares US Pharmaceuticals ETF position peaked at $902K in Q3 2021.
155 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2024.

Based on Flow Traders U.S.'s 13F filing for Q4 2024, filed 14 Feb 2025.